Searched for
FIXED DOSE COMBINATION DRUGS BANNED LIST
BPSC releases CCE final result: Shraddha Pandey secures first rank; check detailsShraddha Pandey has topped the Bihar Public Service Commission's 70th CCE, achieving 593 marks. The final results, following interviews for...- 16 fixed-dose combination drugs banned in India: Check full list hereFixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...
- India shows that forcing teens off their phones isn’t always goodThe UK's initiative to restrict social media access for individuals under 16 mimics India's stance, rooted in fears surrounding child well-...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- HPV vaccination drive reaches 50 lakh girls in three monthsIndia's free Human Papillomavirus vaccination drive is making significant progress. Nearly 50 lakh doses of the cervical cancer vaccine hav...
- InCred Money gets Sebi in-principle nod for mutual fund licence, plans launch in 6-9 monthsInCred Money has secured Sebi's in-principle approval for a mutual fund licence, marking a key step toward launching its asset management b...
- Liotech Industries IPO opens for subscription today. Check GMP, price band and other detailsLiotech Industries has fixed the issue price at Rs 321 per share. The IPO is a combination of a fresh issue of 9 lakh shares aggregating Rs...
- Government prescribes end to over-the-counter sale of cough syrupsEven in small villages with a population of less than 1,000, where certain remedies including cough syrups were allowed to be sold without ...
- Centre mandates prescription for syrup-based medicinesChemists must now have a doctor's prescription to sell cough syrups. The government has changed the Drugs Rules, 1945. This stops over-the-...
- Govt ends over-the-counter sales of all 'syrups'; mandates doctor's prescription for purchaseThe Union Ministry of Health and Family Welfare has mandated that all syrups, including cough syrups, are now prescription-only. This new r...
- Sarvam’s unicorn raise; Big exits in new IPOsHappy Tuesday! Sarvam has vaulted into the unicorn club after a fresh funding round. This and more in today’s ETtech Morning Dispatch.
- Sarvam joins unicorn club; Razorpay lines up IPOFresh funding has propelled Sarvam AI into the unicorn club. This and more in today’s ETtech Top 5.
- US Stock Market: Heavy demand anticipated as SpaceX options begin trading this weekOptions trading on SpaceX is expected to begin as early as Tuesday, giving investors new ways to hedge, speculate, and gain leveraged expos...
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- Saudi Arabia lifts 5-year ban on Lebanese imports, marking a thaw in Gulf-Lebanon tiesAfter a five-year hiatus, Saudi Arabia is reopening its market to Lebanese imports, a decision that stemmed from previous drug smuggling ap...
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
Load More
